Back to results
US 2023/0406815 A1Published application
Crystalline prostacyclin (ip) receptor agonist and uses thereof
AssigneeUnited Therapeutics Corporation
InventorKenneth PHARES
Life of this patent
Estimating the term…
Abstract
Described herein are crystalline forms of a prostacyclin (IP) receptor agonist compound, as well as pharmaceutical compositions thereof, and methods of use thereof in the treatment of diseases or conditions that would benefit from treatment with a prostacyclin (IP) receptor agonist compound.
Claims21
1-43. (canceled)
An amorphous form of ralinepag that is characterized as having an X-Ray powder diffraction (XRPD) pattern showing a lack of crystallinity, as shown in FIG. 5.
A crystalline form of ralinepag that is characterized as having:
- a) an XRPD pattern substantially the same as shown in FIG. 1 as measured using Cu Kα.radiation;
- or
- an XRPD pattern with peaks at 8.8±0.2°2-Theta, 11.7±0.2°2-Theta, and 16.2±0.2°2-Theta as measured using Cu Kα.radiation;
- or
- a Thermogravimetric/Differential Thermal Analysis (TGA/DTA) thermogram substantially the same as shown in FIG. 6;
- or
- a Differential Scanning Calorimetry (DSC) thermogram substantially the same as shown in FIG. 7;
- or
- unit cell parameters substantially equal to the following at 100 K:
- Crystal System
- triclinic
- Space Group
- P-1
- a (Å)
- 10.1269(9)
- b (Å)
- 10.7838(8)
- c (Å)
- 11.1906(8
- α (°)
- 80.888(3
- β (°)
- 71.953(3)
- γ (°)
- 68.331(4)
- Volume (Å3)
- 1078.51(15)
- Z, Z′
- 2, 1
- Calculated Density (g/cm3)
- 1.330
- Absorption coefficient (mm−1)
- 1.858
- F(000)
- 456.0
- or
- a reversible water uptake of at most 0.2% (w/w) between 0% and 90% Relative Humidity (RH) as determined by Dynamic Vapour Sorption (DVS);
- or
- an unchanged XRPD pattern after DVS analysis between 0% and 90% RH;
- or
- b) an XRPD pattern substantially the same as shown in FIG. 2 as measured using Cu Kα.radiation;
- or
- an XRPD pattern with peaks at 4.1±0.2°2-Theta, 15.5±0.2°2-Theta, and 16.9±0.2°2-Theta as measured using Cu Kα.radiation;
- or
- a Thermogravimetric/Differential Thermal Analysis (TGA/DTA) thermogram substantially the same as shown in FIG. 8;
- or
- a TGA/DTA thermogram showing weak endothermic and exothermic events from 81 to 89° C. and a broad endothermic event having an onset at about 124.7° C.;
- or
- c) an XRPD pattern substantially the same as shown in FIG. 3 as measured using Cu Kα.radiation;
- or
- an XRPD pattern with peaks at 3.6±0.2°2-Theta, 18.7±0.2°2-Theta, and 22.2±0.2°2-Theta as measured using Cu Kα.radiation;
- or
- a Thermogravimetric/Differential Thermal Analysis (TGA/DTA) thermogram substantially the same as shown in FIG. 9;
- or
- d) an XRPD pattern substantially the same as shown in FIG. 4 as measured using Cu Kα.radiation;
- or
- an XRPD pattern with peaks at 15.0±0.2°2-Theta, 16.7±0.2°2-Theta, and 18.0±0.2°2-Theta as measured using Cu Kα.radiation;
- or
- a Thermogravimetric/Differential Thermal Analysis (TGA/DTA) thermogram substantially the same as shown in FIG. 10.
56 more elements
Dependencies are inferred from the claim text.